Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01708603
Brief Title: P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis (AMAGINE-2)

First Submitted : September 12, 2012
First Submitted that Met QC Criteria : October 15, 2012
First Posted : October 17, 2012 (Estimate)

Results First Submitted : October 31, 2016
Results First Submitted that Met QC Criteria : January 3, 2020
Results First Posted : January 6, 2020

Certification/Extension First Submitted : April 20, 2015
Certification/Extension First Submitted that Met QC Criteria : April 20, 2015
Certification/Extension First Posted : May 7, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 3, 2020
Last Update Posted : January 6, 2020